Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE(R) (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference
Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE(R) (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical Dermatology Conference GlobeNewswire October 24, 2025 New data from Phase 3 studies show once-daily ZORYVE cream helped reduce sleep disruptions in individuals with atopic dermatitis aged greater-than or […]